Crossmark

Subgroup limitations and imaging variability in palivizumab studies: implications for public health assessment

Published Online: 2025-10-16

Authors

Yu, Peijin

Wu, Zexiang
License Information

Text and Data Mining valid from 2025-10-16

Version of Record valid from 2025-10-16
More Information

Article History

Received: 29 September 2025

Revised: 29 September 2025

Accepted: 4 October 2025

First Online: 16 October 2025

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current